Nipah virus infection
Structure of a Henipavirus
SpecialtyInfectious diseases 
SymptomsFever, headache, myalgia, vomiting, cough, sore throat, difficulty breathing, dizziness, drowsiness, altered consciousness[1][2]
ComplicationsEncephalitis, seizures, acute respiratory distress, coma[1][2]
Usual onset4 to 14 days after exposure[1][2]
CausesNipah virus (spread by direct contact)[1]
Diagnostic methodBased on symptoms, confirmed by laboratory testing[1]
PreventionAvoiding exposure to bats and to sick pigs and people.[1]
TreatmentSupportive care only[1][2]
Prognosis40–75% case fatality rate[2]
Frequency~701 human cases (1998 to May 2018)[3][4]

Nipah virus infection is a zoonotic viral disease by the Nipah virus. Results of human contraction range from asymptomatic infection to influenza-like illness or even fatal encephalitis. Initial signs and symptoms, if any, include fever, headache, myalgia, vomiting and signs of respiratory illness such as coughing, a sore throat and difficulty breathing. In severe cases patients may develop encephalitis, which can lead to dizziness, drowsiness, altered consciousness and seizures. Patients with these symptoms can fall into a coma within a day or two.

The Nipah virus (NiV) is a type of RNA virus in the genus Henipavirus, which normally circulates among fruit bats of the genus Pteropus.[5] Spread typically requires direct contact with an infected source; it can both spread between people and from other animals to people. Diagnosis is based on symptoms and confirmed by laboratory testing.[6][2]

Management is restricted to supportive care; as of 2024 there is neither vaccine nor specific treatment.[6] Preventive measures include avoiding exposure to bats and infected animals such as pigs, and not drinking raw date palm sap.[1] The case fatality rate is estimated between 40% and 75%.[1][2][3][7][4]

The disease was first identified in 1998 by a team of researchers at the Faculty of Medicine, University of Malaya during an outbreak in Malaysia.[2] The majority of the patients in Malaysia diagnosed with the disease were referred to and treated at the University of Malaya Medical Centre. The disease is named after a village in Malaysia, Sungai Nipah. Pigs may also be infected, and millions were culled by Malaysian authorities in 1999 to successfully stop the spread of the disease.[2][8]

Signs and symptoms

Human contraction of the virus may lead to asymptomatic infection, acute respiratory infection or fatal encephalitis. Clinical signs typically manifest within 3–14 days which include fever and headache, often accompanied by a cough, throat soreness, difficulty breathing, and other common signs of respiratory illness.[1] Patients may also initially present with symptoms of myalgia and vomiting.[2]

This can be followed by dizziness, drowsiness, altered consciousness, and neurological signs that indicate acute encephalitis. Some people can also experience atypical pneumonia and severe respiratory problems, including acute respiratory distress. Encephalitis and seizures occur in severe cases, progressing to coma within 24 to 48 hours.[1][2]

The incubation period is from 4 to 14 days but an incubation period as long as 45 days has been reported.[2]

Death occurs in 40–75% of cases, and some long-term side effects of infection include persistent convulsions and personality changes. Most survivors make a full recovery, although some are left with residual neurological conditions after acute encephalitis. Some cases of relapse have been reported.[2]

Transmission

The initial case in human outbreaks of Nipah virus has always been zoonotic[2] from exposure to contaminated secretions or tissues of infected bats or pigs. Subsequent human-to-human transmission of Nipah virus occurs via close contact with NiV-infected persons or exposure to NiV-infected body fluids (e.g., blood, urine, nasal secretions).[2]

Most experts do not classify Nipah virus as airborne, though there is consensus that transmission can—and does—occur from short-range exposure to NiV-infected respiratory droplets in close contact settings.[9]

Indirect transmission of Nipah virus via contaminated fomites is likely responsible for many cases in which there was no known direct contact with a NiV-infected person or animal.

Risk factors

The risk of exposure is high for hospital workers and caretakers of those infected with the virus. In Malaysia and Singapore, Nipah virus infected people with close contact to infected pigs. In Bangladesh and India, the disease has been linked to consumption of raw date palm sap (toddy), eating of fruits partially consumed by bats, and using water from wells inhabited by bats.[10][11]

Diagnosis

Nipah infection can be diagnosed during illness or after recovery. During early stages of infection, Nipah can be tested for using real time polymerase chain reaction from throat and nasal swabs, cerebrospinal fluid, urine, or blood. Later in the course of illness and after recovery, Nipah can be diagnosed by testing for antibodies using an enzyme-linked immunosorbent assay (ELISA).[6] AI-assisted blood test analysis platforms have also been explored for supporting early detection of viral biomarkers associated with Nipah virus infection.[13][14]

Prevention

Prevention through sanitary practices is the best protection. The likelihood of infection through animal transmission can be reduced by avoiding exposure to sick pigs, and to bats where the disease is endemic. Bats harbor a significantly higher proportion of zoonotic viruses than all other mammalian orders,[15] and are known not to be affected by the many viruses they carry, apparently due to their developing special immune systems to deal with the stress of flying.[16]

Infection via bats can be caused by drinking raw palm sap (palm toddy) contaminated by bat excreta,[17] eating fruits partially consumed by bats, and using water from wells infested by bats.[11] Bats are known to drink toddy that is collected in open containers, and occasionally urinate in it, which contaminates it with the virus.[17]

Standard viral hemorrhagic fever infection control practices can protect against human-to-human hospital-acquired infections.[6] These include isolating patients, using personal protective equipment (PPE), and maintaining strict hand hygiene practices. Individuals identified through contact tracing are tested and monitored until confirmed negative. Healthcare facilities must enforce rigorous infection prevention protocols when caring for suspected or confirmed cases.[18]

In January 2024 a candidate vaccine, ChAdOx1 NipahB, commenced Phase I clinical trials after completing laboratory and animal testing.[19][20]

Treatment

As of 2024, there is no specific treatment for Nipah virus infection.[1] The mainstay of treatment is supportive care, including rest, hydration, and treatment of symptoms.[6] Ribavirin was used to treat a small number of patients during the original 1999 outbreak in Malaysia, but its efficacy is unclear.[1]Acyclovir, favipiravir,[21] and remdesivir[22] have been assessed as potential antivirals against Nipah virus.

Prognosis

Nipah virus infection may cause a mortality rate of anywhere between 40 to 75% as seen in previous outbreaks with significant clinical cases.[2][23]

Those who survive the initial infection often struggle with debilitating long-term neurological sequelae, including memory loss, impaired cognition, seizures, convulsions, and personality changes.[2]

Moreover, Nipah virus is known to be able to persist and lie dormant in survivors and to re-activate many months or years after the initial infection. Deaths from re-activation of latent Nipah virus have been reported.[24]

Outbreaks

Nipah virus outbreaks have been reported in Malaysia, Singapore, Bangladesh and India. The area is known as the Nipah Belt. The highest mortality due to Nipah virus infection was found in Bangladesh, where outbreaks are typically seen in winter.[25] Nipah virus was first seen in 1998 in peninsular Malaysia in pigs and pig farmers. By mid-1999, more than 265 human cases of encephalitis, including 105 deaths, had been reported in Malaysia, and 11 cases of either encephalitis or respiratory illness with one fatality were reported in Singapore.[26]

In 2001, Nipah virus was reported from Meherpur District, Bangladesh[27][28] and Siliguri, India.[27] The outbreak again appeared in 2003, 2004 and 2005 in Naogaon District, Manikganj District, Rajbari District, Faridpur District and Tangail District.[28] In Bangladesh there were further outbreaks in subsequent years.[29][7]

Research

Ribavirin, m102.4 monoclonal antibody, and favipiravir were being studied as treatments as of 2019.[57]

Medication

Ribavirin has been studied in a small number of people. As of 2011, it was unclear whether it was useful, although a few people had returned to normal life after treatment.[58] In vitro studies and animal studies have shown conflicting results in the efficacy of ribavirin against NiV and Hendra, with some studies showing effective inhibition of viral replication in cell lines,[59][60] whereas some studies in animal models showed that ribavirin treatment only delayed but did not prevent death after NiV or Hendra virus infection.[61][62]

In 2013, the anti-malarial drug chloroquine was shown to block the critical functions needed for maturation of Nipah virus, although no clinical benefit was observed.[3]

Immunization

Passive immunization using a human monoclonal antibody, m102.4, that targets the ephrin-B2 and ephrin-B3 receptor-binding domain of the henipavirus Nipah G glycoprotein was evaluated in the ferret model as post-exposure prophylaxis.[3] m102.4 has been used in people on a compassionate use basis in Australia, and was in pre-clinical development in 2013.[3]

Society and culture

The fictional MEV-1 virus featured in the 2011 film Contagion was based on a combination of Nipah and measles virus.[63]

A Malayalam movie, Virus, was released in 2019, based on the 2018 outbreak of Nipah virus in Kerala, India.[64][65]

In series 4 episode 1 of The Good Karma Hospital, a patient is admitted with Nipah.

Episode 7 of the Korean drama Doctor John also features a Nipah virus outbreak.

See also

References

  1. "About Nipah Virus". U.S. Centers for Disease Control and Prevention. 23 February 2024.
  2. "Nipah Virus Infection". who.int. World Health Organization. 30 May 2018.
  3. Broder CC, Xu K, Nikolov DB, Zhu Z, Dimitrov DS, Middleton D, et al. (October 2013). "A treatment for and vaccine against the deadly Hendra and Nipah viruses". Antiviral Research. 100 (1): 8–13. doi:10.1016/j.antiviral.2013.06.012. PMC 4418552. PMID 23838047.
  4. "Morbidity and mortality due to Nipah or Nipah-like virus encephalitis in WHO South-East Asia Region, 2001–2018" (PDF). SEAR. Archived from the original (PDF) on 13 June 2018. 112 cases since Oct 2013
  5. Singh RK, Dhama K, Chakraborty S, Tiwari R, Natesan S, Khandia R, et al. (1 January 2019). "Nipah virus: epidemiology, pathology, immunobiology and advances in diagnosis, vaccine designing and control strategies – a comprehensive review". Veterinary Quarterly. 39 (1): 26–55. doi:10.1080/01652176.2019.1580827. ISSN 0165-2176. PMC 6830995. PMID 31006350.
  6. "Nipah virus: Facts for Clinicians". U.S. Centers for Disease Control and Prevention. 25 March 2024. Archived from the original on 25 January 2026.
  7. "Nipah virus outbreaks in the WHO South-East Asia Region". South-East Asia Regional Office. WHO. Archived from the original on 23 May 2018.
  8. "Seven things you need to know about Nipah virus | Gavi, the Vaccine Alliance". www.gavi.org. 15 September 2023.
  9. "Nipah virus airborne". Australian Veterinary Journal. 77 (9): 558. 1999. doi:10.1111/j.1751-0813.1999.tb13182.x.
  10. Luby SP, Gurley ES, Hossain MJ (2012). Transmission of Human Infection with Nipah Virus. National Academies Press (US). Archived from the original on 22 May 2018.
  11. Balan S (21 May 2018). "6 Nipah virus deaths in Kerala: Bat-infested house well of first victims sealed". The News Minute. Archived from the original on 22 May 2018.
  12. "Nipah Virus Infection symptoms, causes, treatment, medicine, prevention, diagnosis". myUpchar.
  13. Klein T, Mitchell S, Weber H (February 2026). Kantesti AI Blood Test Analyzer - Nipah Virus Early Detection Sample Report 2026 (Report). Zenodo. doi:10.5281/zenodo.18487418.
  14. "Nipah Virus Blood Test Early Detection Diagnosis Guide". Kantesti.
  15. Olival KJ, Hosseini PR, Zambrana-Torrelio C, Ross N, Bogich TL, Daszak P (2017). "Host and viral traits predict zoonotic spillover from mammals". Nature. 546 (7660): 646–650. Bibcode:2017Natur.546..646O. doi:10.1038/nature22975. ISSN 0028-0836. PMC 5570460. PMID 28636590.
  16. Huang P (9 February 2020). "Bats Carry Many Viruses. So Why Don't They Get Sick?". National Public Radio (npr).
  17. Islam MS, Sazzad HM, Satter SM, Sultana S, Hossain MJ, Hasan M, et al. (April 2016). "Nipah Virus Transmission from Bats to Humans Associated with Drinking Traditional Liquor Made from Date Palm Sap, Bangladesh, 2011–2014". Emerging Infectious Diseases. 22 (4): 664–70. doi:10.3201/eid2204.151747. PMC 4806957. PMID 26981928.
  18. Aditi, Shariff M (January 2019). "Nipah virus infection: A review". Epidemiology & Infection. 147 e95. doi:10.1017/S0950268819000086. ISSN 0950-2688. PMC 6518547. PMID 30869046.
  19. "First in-human vaccine trial for Nipah virus". Oxford Vaccine Group. 11 January 2024.
  20. Doremalen Nv, Avanzato VA, Feldmann F, Schulz JE, Haddock E, Okumura A, et al. (2022). "ChAdOx1 NiV vaccination protects against lethal Nipah Bangladesh virus infection in African green monkeys". npj Vaccines. 7 (1) 171. bioRxiv 10.1101/2021.07.20.452991. doi:10.1038/s41541-022-00592-9. PMC 9768398. PMID 36543806.
  21. Sharma V, Kaushik S, Kumar R, Yadav JP, Kaushik S (January 2019). "Emerging trends of Nipah virus: A review". Reviews in Medical Virology. 29 (1) e2010. doi:10.1002/rmv.2010. PMC 7169151. PMID 30251294.
  22. Lo MK, Feldmann F, Gary JM, Jordan R, Bannister R, Cronin J, et al. (29 May 2019). "Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge". Science Translational Medicine. 11 (494) eaau9242. doi:10.1126/scitranslmed.aau9242. ISSN 1946-6234. PMC 6732787. PMID 31142680.
  23. Shoemaker T, Choi MJ (24 June 2019). "Henipaviruses – Chapter 4 – 2020 Yellow Book | Travelers' Health | CDC". Centers for Disease Control and Prevention.
  24. "Nipah virus: epidemiology, outbreaks and guidance". Public Health England. 30 May 2018.
  25. Chadha MS, Comer JA, Lowe L, Rota PA, Rollin PE, Bellini WJ, et al. (February 2006). "Nipah virus-associated encephalitis outbreak, Siliguri, India". Emerging Infectious Diseases. 12 (2): 235–40. doi:10.3201/eid1202.051247. PMC 3373078. PMID 16494748.
  26. Eaton BT, Broder CC, Middleton D, Wang LF (January 2006). "Hendra and Nipah viruses: different and dangerous". Nature Reviews. Microbiology. 4 (1): 23–35. doi:10.1038/nrmicro1323. PMC 7097447. PMID 16357858. S2CID 24764543.
  27. Chadha MS, Comer JA, Lowe L, Rota PA, Rollin PE, Bellini WJ, et al. (February 2006). "Nipah virus-associated encephalitis outbreak, Siliguri, India". Emerging Infectious Diseases. 12 (2): 235–40. doi:10.3201/eid1202.051247. PMC 3373078. PMID 16494748.
  28. Hsu VP, Hossain MJ, Parashar UD, Ali MM, Ksiazek TG, Kuzmin I, et al. (December 2004). "Nipah virus encephalitis reemergence, Bangladesh". Emerging Infectious Diseases. 10 (12): 2082–7. doi:10.3201/eid1012.040701. PMC 3323384. PMID 15663842.
  29. "Basic preventive measures can reduce Nipah virus attack". The Daily Star (Bangladesh). 8 March 2008.
  30. Looi LM, Chua KB (2007). "Lessons from the Nipah virus outbreak in Malaysia" (PDF). The Malaysian Journal of Pathology. 29 (2). Department of Pathology, University of Malaya and National Public Health Laboratory of the Ministry of Health, Malaysia: 63–7. PMID 19108397. Archived (PDF) from the original on 30 August 2019.
  31. Chadha MS, Comer JA, Lowe L (2006). "Nipah virus-associated encephalitis outbreak, Siliguri, India". Emerging Infectious Diseases. 12 (2): 235–40. doi:10.3201/eid1202.051247. PMC 3373078. PMID 16494748.
  32. Hsu VP, Hossain MJ, Parashar UD (2004). "Nipah virus encephalitis reemergence, Bangladesh". Emerging Infectious Diseases. 10 (12): 2082–7. doi:10.3201/eid1012.040701. PMC 3323384. PMID 15663842.
  33. ICDDR,B (December 2005). "Nipah virus outbreak from date palm juice" (PDF). Centre for Population Research – Health and Science Bulletin. 3 (4): 1–5. ISSN 1729-343X. Archived from the original (PDF) on 22 July 2020.
  34. "Person-to-person transmission of Nipah infection in Bangladesh" (PDF). Health and Science Bulletin. 5 (4): 1–6. December 2007. ISSN 1729-343X. Archived from the original on 3 February 2009.
  35. ICDDR,B (2008). "Outbreaks of Nipah virus in Rajbari and Manikgonj". Health and Science Bulletin. 6 (1): 12–3. Archived from the original on 3 February 2009.
  36. ICDDR,B (2010). "Nipah outbreak in Faridpur District, Bangladesh, 2010". Health and Science Bulletin. 8 (2): 6–11. Archived from the original on 28 September 2011.
  37. "Arguments in Bahodderhat murder case begin". The Daily Star. 18 March 2008.
  38. তাহেরকে ফাঁসি দেওয়ার সিদ্ধান্ত নেন জিয়া. prothom-alo.com. 4 February 2011
  39. "Nipah virus outbreak: Death toll rises in Kerala, two more cases confirmed". indianexpress.com. 27 May 2018.
  40. "Kozhikode on high alert as three deaths attributed to Nipah virus". The Indian Express. 20 May 2018.
  41. "Deadly Nipah virus claims victims in India". BBC News. 21 May 2018.
  42. "Kerala Govt Confirms Nipah Virus, 86 Under Observation". New Delhi. 4 June 2019. Archived from the original on 14 July 2019.
  43. Sharma NC (4 June 2019). "Centre gears up to contain re-emergence of Nipah virus in Kerala". Mint.
  44. "Ernakulam district declared Nipah virus free, says Kerala health minister". India Today. Press Trust of India. 23 July 2019.
  45. "Nipah in Kozhikode: Health Minister Veena George says next one week crucial". OnManorama.
  46. "Nipah returns to Kerala, 12-year-old dead in Kozhikode". The Indian Express. 5 September 2021.
  47. "Nipah Back to Haunt Kerala as 12-Yr-Old Succumbs to Virus. Symptoms, Treatment & All You Must Know". News18. 5 September 2021.
  48. Unnithan PS (5 September 2021). "12-year-old boy dies of Nipah virus in Kerala's Kozhikode". India Today.
  49. "Authorities race to contain deadly Nipah virus outbreak in India". www.cbsnews.com. 7 September 2021.
  50. "Nipah virus infection – Bangladesh".
  51. "Nipah outbreak | Number of cases rises to 5 in Kerala; 789 contacts kept under watch". The Hindu. 13 September 2023. ISSN 0971-751X.
  52. Millson A (14 September 2023). "What Is Nipah and Why Is the Deadly Virus Flaring Up Again". Bloomberg.com.
  53. "Nipah virus: Kerala state issues alert after 14-year-old dies". BBC News. 21 July 2024.
  54. "Nipah death again in Kerala, 14-year-old boy under treatment dies at Kozhikode MCH". The Hindu. 21 July 2024.
  55. Conversation T (2 February 2026). "Nipah Virus Outbreak Has Asia on High Alert Amid Deaths in India". ScienceAlert.
  56. Muzaffar M (23 January 2026). "Nipah virus symptoms explained as deadly outbreak spreads in India". The Independent.
  57. Banerjee S, Gupta N, Kodan P, Mittal A, Ray Y, Nischal N, et al. (February 2019). "Nipah virus disease: A rare and intractable disease". Intractable & Rare Diseases Research. 8 (1): 1–8. doi:10.5582/irdr.2018.01130. PMC 6409114. PMID 30881850.
  58. Vigant F, Lee B (June 2011). "Hendra and nipah infection: pathology, models and potential therapies". Infectious Disorders Drug Targets. 11 (3): 315–36. doi:10.2174/187152611795768097. PMC 3253017. PMID 21488828.
  59. Wright PJ, Crameri G, Eaton BT (March 2005). "RNA synthesis during infection by Hendra virus: an examination by quantitative real-time PCR of RNA accumulation, the effect of ribavirin and the attenuation of transcription". Archives of Virology. 150 (3): 521–32. doi:10.1007/s00705-004-0417-5. PMID 15526144. S2CID 23885676.
  60. Aljofan M, Saubern S, Meyer AG, Marsh G, Meers J, Mungall BA (June 2009). "Characteristics of Nipah virus and Hendra virus replication in different cell lines and their suitability for antiviral screening". Virus Research. 142 (1–2): 92–9. doi:10.1016/j.virusres.2009.01.014. PMC 2744099. PMID 19428741.
  61. Georges-Courbot MC, Contamin H, Faure C, Loth P, Baize S, Leyssen P, et al. (May 2006). "Poly(I)-poly(C12U) but not ribavirin prevents death in a hamster model of Nipah virus infection". Antimicrobial Agents and Chemotherapy. 50 (5): 1768–72. doi:10.1128/AAC.50.5.1768-1772.2006. PMC 1472238. PMID 16641448.
  62. Freiberg AN, Worthy MN, Lee B, Holbrook MR (March 2010). "Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infection". The Journal of General Virology. 91 (Pt 3): 765–72. doi:10.1099/vir.0.017269-0. PMC 2888097. PMID 19889926.
  63. "Nipah virus inspired "Contagion." We're testing a vaccine". www.path.org.
  64. Virus
  65. "Virus Movie Review {3.5/5}: A well-crafted multi-starrer, fictional documentation on the Nipah virus attack", The Times of India
Wikimedia Commons has media related to Nipah virus infection.